U.S. telehealth giant Hims & Hers acquires Canadian platform Livewell, positioning itself to launch generic semaglutide (Ozempic) in Canada as Novo Nordisk's patent lapses. The move targets a market where two-thirds of adults face weight-related health ch
The World Health Organization has officially endorsed GLP-1 receptor agonist treatments, including drugs like Ozempic, as a key tool to tackle the global obesity epidemic. Learn what this means for public health.
Experts warn injectable weight-loss drugs such as Ozempic are reducing consumer appetites, posing a significant challenge to the fast-food sector's traditional business model in Canada.
New research reveals how diabetes medications Ozempic and Wegovy are transforming Canadian shopping patterns and food consumption. Discover the surprising impacts.
Two million Canadians using GLP-1 drugs like Ozempic are dramatically changing food consumption patterns, removing $3.3 billion annually from Canada's food economy. Learn how this trend affects groceries, restaurants and agriculture.
Discover why some patients experience hair loss while taking GLP-1 medications like Ozempic. Learn about the science behind this side effect and expert recommendations.
Discover the truth about 'Ozempic penis' - the viral claim about GLP-1 medications. Urologists explain why it's an optical illusion and reveal real sexual side effects.
Celebrity chef Gordon Ramsay refuses to create menus for diners on weight-loss drugs like Ozempic, sparking debate. Discover his controversial stance and its potential impact.
Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.